OncoDNA’s aim is to provide medical innovations based on targeted sequencing or complete sequencing of tumour genomes, in order to assist medical doctors in their treatment choices and/or give better monitoring of the evolution of patient tumors. The ambition is to be a European reference for personalized analysis in oncology, based on the analysis of tumour’s DNA from patients. OncoDNA provides innovative analyses to private hospitals, research centres and pharmaceutical clients.
Business Needs: Direct Sales, Distributor/Agent/Representative, Investor
Products to be exported: OncoDEEP, OncoSELECT, OncoTRACE, OncoSTRAT&GO